z-logo
open-access-imgOpen Access
Differences Between Randomized Clinical Trial Participants and Real-World Empagliflozin Users and the Changes in Their Glycated Hemoglobin Levels
Author(s) -
Nicolai Egholt Munk,
Jakob S. Knudsen,
Anton Pottegård,
Daniel R. Witte,
Reimar W. Thomsen
Publication year - 2020
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2019.20949
Subject(s) - empagliflozin , medicine , glycated hemoglobin , randomized controlled trial , interquartile range , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes , endocrinology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom